Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | € 54.30M | € 60.57M | € 48.59M | € 46.95M | € 40.71M |
Total Assets | € 113.36M | € 130.20M | € 130.94M | € 140.76M | € 163.50M |
Total Debt | € 81.95M | € 94.47M | € 94.88M | € 100.41M | € 102.92M |
Net Debt | € 27.64M | € 33.90M | € 46.28M | € 53.46M | € 62.21M |
Total Liabilities | € 111.42M | € 129.73M | € 149.66M | € 158.10M | € 177.10M |
Stockholders Equity | € 1.49M | € 87.00K | € -19.06M | € -17.68M | € -13.91M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |